High Precision and Greater Adoption from End Users to Drive Global PCR and Real Time PCR Molecular Diagnostic Market in Near Future

In the past few years, there has been a growing uptake of polymerase chain reaction or PCR molecules for the diagnosis of pathogenic DNA. These pathogenic DNA are responsible for several contagious diseases. Numerous efforts are underway to broaden the scope of the PCR and RT-PCR tests to uncover new diagnostic treatments and therapeutics for such life-threatening ailments.

global PCR and real-time PCR molecular

In terms of the technology, the global PCR and real time PCR molecular diagnostic market is expected to be dominated by the RT-PCR tests. These tests are expected remain a lucrative prospect due to its higher sensitivity, timely processing of diagnostic results, improved precision, lesser probabilities of contamination. All these factors also contribute to limiting the error margins. Adoption rate of these RT-PCR tests have particularly surged during the on-going COVID-19 pandemic.

Similarly, digital PCR or dPCR tests are also gaining momentum in the markets. This growth in uptake is attributed to growing penetration of smart technology across the healthcare domain. In addition to this, digital PCR tests do not need any calibration against industry standards. This particular aspect is vital for the RT-PCR tests. In addition to this, dPCR diagnostic tests can also detect more number of samples compared to the conventional PCR tests.

Oncology Domain to Provide Significant Growth Opportunities

The segment of testing for infectious disease is expected to gain high growth in the coming years of the forecast period ranging from 2020 to 2030. The high growth of the segment is mainly driven by growing prevalence of sexually transmitted diseases and infections, hepatitis B and C, and respiratory infections among others. In coming years, the growth of the segment is expected to gain even more traction as the repercussions of COVID-19 pandemic continue to impact the globe and drive the uptake of PCR and real-time PCR molecular diagnostic market.

At the same time, oncology is expected to emerge as a key area of application. Constant innovations and technological breakthroughs are expected to improve the PCR and real time PCR molecular diagnostic market in detecting, diagnosing, and treating wide range of cancers on a greater scale. The segment is projected to bring in a considerable revenue share for the global PCR and real time PCR molecular diagnostic market in the coming years of the forecast period.

North America to Remain in Driving Seat During Forecast Period

In terms of regional segmentation, the global PCR and real time PCR molecular diagnostics market is divided into five key regions. These regions are North America, Latin America, Middle East and Africa, Europe, and Asia Pacific. Of these, the regional segment of North America is expected to remain in the driving seat in the coming years of the forecast period. The region is expected offer highly promising growth opportunities because of superior technological growth and increasing uptake from the end users.

Some of the key players in the global PCR and real tome PCR molecular diagnostic market are Abbott Laboratories, bioMerieux SA, Danaher Corporation, and Bio-Rad Laboratories among others.

4.7 Star App Store Review!
The Communities are great you rarely see anyone get in to an argument :)
Love Love LOVE

Select Collections